Ignite Creation Date:
2024-05-05 @ 6:47 PM
Last Modification Date:
2024-10-26 @ 9:37 AM
Study NCT ID:
NCT00545883
Status:
COMPLETED
Last Update Posted:
2012-01-26
First Post:
2007-10-15
Brief Title:
Impact of GERD on Daily Life NIS
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Study Overview
Official Title:
An Epidemiological Observational Study to Describe Symptom Control and Impact on Daily Life of GERD in Patients With Erosive Gastroesophageal Reflux Disease
Status:
COMPLETED
Status Verified Date:
2012-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
Alegria
Brief Summary:
The aim of this study is to gather epidemiological data in a population of GERD patients in primary care with a history of erosive esophagitis less than or equal to 3 years
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None